GuidelineCurrent oncology (Toronto, Ont.)2025

Multidisciplinary Practical Guidance for Implementing Adjuvant CDK4/6 Inhibitors for Patients with HR-Positive, HER2-Negative Early Breast Cancer in Canada.

Katarzyna J Jerzak et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.